Concert Pharmaceuticals Inc (NASDAQ:CNCE)

17.54
Delayed Data
As of Mar 21
 +0.40 / +2.33%
Today’s Change
10.80
Today|||52-Week Range
24.19
+39.76%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Concert Pharmaceuticals Inc have a median target of 26.00, with a high estimate of 27.00 and a low estimate of 17.00. The median estimate represents a +48.23% increase from the last price of 17.54.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Concert Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.76
Sales
$0.00
Reporting Date
May 06

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 15.17%
 
 
 
 
 
 
Growthannually -37.75%
 
 
 
 
 
 

Sales

Growthquarterly -100.00%
 
 
 
 
 
 
Growthannually -17.26%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.